Archive


Category: ~$3.2B

  • Sanofi to Acquire Translate Bio for ~$3.2B

    Shots: Sanofi to acquire all outstanding shares of Translate Bio for $38.00/share in cash making a total equity value of ~$3.2B with a premium of 30.4% to Translate Bio’s one day prior closing price of $29.15. The acquisition is expected to complete in the Q3’21 The acquisition will utilize mRNA technology to further accelerates Sanofi’s […]